Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(0.24)
# 4,455
Out of 5,143 analysts
20
Total ratings
23.08%
Success rate
-29.47%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintains: Buy | $64 → $66 | $45.32 | +45.63% | 2 | Nov 12, 2025 | |
| CELH Celsius Holdings | Maintains: Neutral | $62 → $58 | $55.24 | +5.00% | 3 | Mar 27, 2025 | |
| ECOR electroCore | Maintains: Buy | $28 → $26 | $7.04 | +269.32% | 2 | Mar 13, 2025 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $2.12 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $4.00 | - | 1 | Oct 5, 2023 | |
| VERO Venus Concept | Maintains: Buy | $536 → $363 | $1.62 | +22,307.41% | 2 | Mar 28, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $3.48 | +2,486.21% | 1 | Aug 4, 2022 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.36 | +414.71% | 1 | Jun 21, 2021 | |
| NNOX Nano-X Imaging | Initiates: Buy | $52 | $3.11 | +1,572.03% | 1 | Apr 19, 2021 | |
| TENX Tenax Therapeutics | Upgrades: Buy | n/a | $14.78 | - | 1 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $42.16 | - | 5 | Apr 27, 2017 |
Harrow
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $66
Current: $45.32
Upside: +45.63%
Celsius Holdings
Mar 27, 2025
Maintains: Neutral
Price Target: $62 → $58
Current: $55.24
Upside: +5.00%
electroCore
Mar 13, 2025
Maintains: Buy
Price Target: $28 → $26
Current: $7.04
Upside: +269.32%
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.12
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $4.00
Upside: -
Venus Concept
Mar 28, 2023
Maintains: Buy
Price Target: $536 → $363
Current: $1.62
Upside: +22,307.41%
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $3.48
Upside: +2,486.21%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.36
Upside: +414.71%
Nano-X Imaging
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $3.11
Upside: +1,572.03%
Tenax Therapeutics
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $14.78
Upside: -
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $42.16
Upside: -